Fund Information

The PRULink Adapt Fund (the "Fund") aims to generate capital growth at a controlled risk level consistent with the investment horizon of the portfolio to accumulate assets and provide wealth for investors at maturity. Beyond the investment horizons which would centre around the 2 maturity periods of 2025 and 2035, the objective is to maintain capital stability in the portfolio.

Each of the Funds invests into other underlying funds and/or invests in equities, bonds and short-term money instruments. The proportions and asset allocation strategy of each Fund may be determined by the Manager. The Funds' asset allocation would be dynamic and would become more conservative over time.

Don't miss this opportunity to select a suitable flexible investment that caters to your financial goals with the PRULink Adapt Fund series.


Launch Date 19 April 2005
Manager of the Funds Schroder Investment Management (Singapore) Limited ("Schroders Singapore")
Benchmark Composite benchmark comprising the MSCI Singapore Free Index, MSCI World, MSCI AC Asia ex-Japan Index, MSCI Emerging Market, Markit iBoxx ALBI Singapore Index, Barclays Capital Global Aggregate Index (hedged to S$), Barclays Capital Global Aggregate Index - Credit Component (hedged to S$), JACI Investment Grade Index (hedged to S$)
CPFIS Risk Classification of Investment-linked Insurance Products Broadly Diversified; Medium to High Risk
Subscription Method CPFIS-OA, CPFIS-SA, Cash and Supplementary Retirement Scheme (SRS)
(PRULink Adapt 2025)
CPFIS-OA, Cash and Supplementary Retirement Scheme (SRS)
(PRULink Adapt 2035)
Initial Investment Charge 5%* of premium invested
Continuing Investment Charge
  • 1.45% per annum (PRULink Adapt 2025)**
  • 1.45% per annum (PRULink Adapt 2035)**


* Please refer to the Product Summary for details of charges incurred on your insurance plan as charges may vary from product to product and may be lower than 5%.

** We reserve the right to vary the continuing investment charge and may increase it up to a maximum of 2% per annum, but we will not do so before giving investors 6 months’ written notice.

Note: Effective 3 December 2018, PruLink Adapt 2035 Fund's risk classification is changed from Higher Risk to Medium to High Risk. It’s continuing investment charge is changed from 1.60% to 1.45%.

As buying a life insurance policy is a long-term commitment, an early termination of the policy usually involves high costs and the surrender value, if any, that is payable to you may be zero or less than the total premiums paid. Investments are subject to investment risks including the possible loss of the principal amount invested.

Past performances of the Fund, the Underlying Fund, Fund Manager and the Investment Manager are not necessarily indicative of future or likely performance of the Fund, the Underlying Fund, Fund Manager and the Investment Manager. A copy of the Fund Information Booklet and Product Highlights Sheet ("PHS") in relation to this Fund may be obtained from your Prudential Financial Consultant. You are advised to read the Fund Information Booklet and PHS before deciding whether to subscribe for units in this Fund.

The prediction, projections, or forecasts on the economy, securities markets or the economic trends of the markets targeted by the Fund are not necessarily indicative of the future or likely performance of the Fund. The value of the units in the Fund and the income accruing to the units (if any) may fall or rise.

You are recommended to seek advice from a qualified Prudential Financial Consultant for a financial analysis before purchasing a policy suitable to meet your needs. This website is for reference only and is not a contract of insurance. Please refer to the exact terms and conditions, specific details and exclusions applicable to this insurance product in the policy documents that can be obtained from a Prudential Financial Consultant.

The information contained on this website is intended to be valid in Singapore only and shall not be construed as an offer to sell or solicitation to buy or provision of any insurance product outside Singapore.

Information is correct as at 10 Dec 2018.

This advertisement has not been reviewed by the Monetary Authority of Singapore.